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Trypanosoma cruzi exhibits In Vivo 
Prostaglandin F2α synthase activity 
and has a Key role in Parasite 
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The discovery that trypanosomatids, unicellular organisms of the order Kinetoplastida, 
are capable of synthesizing prostaglandins raised questions about the role of these 
molecules during parasitic infections. Multiple studies indicate that prostaglandins could 
be related to the infection processes and pathogenesis in trypanosomatids. This work 
aimed to unveil the role of the prostaglandin F2α synthase TcOYE in the establishment 
of Trypanosoma cruzi infection, the causative agent of Chagas disease. This chronic 
disease affects several million people in Latin America causing high morbidity and mor-
tality. Here, we propose a prokaryotic evolutionary origin for TcOYE, and then we used 
in vitro and in vivo experiments to show that T. cruzi prostaglandin F2α synthase plays an 
important role in modulating the infection process. TcOYE overexpressing parasites were 
less able to complete the infective cycle in cell culture infections and increased cardiac 
tissue parasitic load in infected mice. Additionally, parasites overexpressing the enzyme 
increased PGF2α synthesis from arachidonic acid. Finally, an increase in benznidazole 
and nifurtimox susceptibility in TcOYE overexpressing parasites showed its participation 
in activating the currently anti-chagasic drugs, which added to its observed ability to 
confer resistance to hydrogen peroxide, highlights the relevance of this enzyme in multi-
ple events including host–parasite interaction.
Keywords: Trypanosoma cruzi, prostaglandin F2α synthase, Old Yellow enzyme, differentially expressed gene, 
benznidazol and nifurtimox activation
inTrODUcTiOn
Chagas disease or American trypanosomiasis is an endemic zoonosis in South and Central America 
characterized by chronic inflammation and cardiomyopathy, and less frequently, digestive symp-
toms. Although disease pathogenesis remains unclear, it is well known that both parasite and host 
responses play relevant roles. Immediately after adhesion and during the initial stages of infection, 
Trypanosoma cruzi dramatically remodels host cell gene expression profile, with specific patterns on 
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each cell type (1, 2); B and T cell immunity also plays important 
roles both in the control and pathogenesis of the disease (3, 4). 
The low or null parasite cardiac load in patients with chronic cha-
gasic cardiomyopathy lead a discussion in the literature regarding 
the etiology of Chagas disease, where different factors such as 
T. cruzi strains, genetic background of the host, altered immune 
responses, and autoimmunity where associated with clinical 
outcomes of the disease [reviewed in Ref. (5)].
It was not until recently that bioactive lipids were recognized 
as relevant mediators of immune response to T. cruzi both during 
the acute (suppression of host lymphoproliferative responses to 
mitogens and antigens) and chronic (induction of inflamma-
tory reactions in several tissues) phases of the disease (6–8). 
Prostaglandin F2α (PGF2α), thromboxane A2 (TXA2), prostaglan-
din I2 (PGI2), and prostaglandin E2 (PGE2) levels were shown to 
increase in infected mice (8, 9), and T. cruzi-derived eicosanoids 
were proposed as a mechanism of parasite persistence (10) as they 
are involved in disease evolution in favor of progression to the 
chronic stage (11, 12). In this sense, it was proposed that transi-
tion to the chronic phase is affected by the immunomodulatory 
effect of eicosanoids released by T. cruzi, which may contribute to 
parasite proliferation and differentiation, and also to host survival 
(11, 12). Furthermore, TXA2 and PGF2α were found to be the 
most abundant bioactive eicosanoids derived from T. cruzi dur-
ing infection (11).
Although arachidonic acid (AA) metabolism in mammalian 
cells is well-described, prostaglandin pathways in trypanoso-
matids as well as the role of their derived eicosanoids in Chagas 
disease pathogenesis remain unclear. To date, the vast majority of 
characterized PGF2α synthases belong to the Aldo-Keto Reductase 
protein family (13). In trypanosomatids, TbAKR (Trypanosoma 
brucei) and LmAKR (Leishmania major) have PGF2α synthase 
activity (14, 15), whereas the T. cruzi ortholog TcAKR seems to 
lack such activity (16). Interestingly, T. cruzi encodes a member 
of the Old Yellow Enzyme family (TcOYE) that catalyzes PGF2α 
synthesis (11, 17). This flavoprotein NADPH oxidoreductase 
is absent in mammalian and even in other trypanosomatids 
(17, 18). Initially described by Warburg and Christian (19), Old 
Yellow Enzymes are oxidoreductases that use FMN as cofactor 
and can reduce nitro esters, nitroaromatics, or α,β-unsaturated 
compounds (20). Due to the diversity of enzymes belonging 
to OYE family and the wide variety of substrates identified, no 
conserved physiological role has been attributed to them. These 
enzymes have diverse functions associated to detoxification, 
oxidative stress response, and specific metabolic pathways such 
as ergot alkaloid biosynthesis (21).
In vitro experiments have shown that TcOYE not only reduces 
9,11-endoperoxide PGH2 to PGF2α and hydrogen peroxide but 
also is capable of metabolizing a number of trypanocidal drugs 
(17, 22). Although TcOYE can reduce nifurtimox (Nfx) under 
anaerobic conditions, it is not able to reduce benznidazole (Bzn) 
(17). Nevertheless, deletion of TcOYE gene copies as well as a 
decrease in TcOYE transcription has been associated to Bzn 
resistance (23, 24).
The role of TcOYE in host–parasite interactions has not 
been thoroughly assessed since most studies are focused on 
analyzing the in vitro activity of recombinant TcOYE. Here, we 
studied the phylogenetic origin, expression patterns, subcellular 
localization, and overexpression effects of this enzyme evidenc-
ing that TcOYE: (i) exhibits PGF2α synthase activity in  vivo, 
(ii) modulates parasite progression into infective forms during 
the intracellular stages, (iii) augments parasitic load on mice 
heart muscle, and (iv) confers Bzn and Nfx susceptibility and 
hydrogen peroxide resistance.
resUlTs
Phylogenetic analysis of Old Yellow 
enzyme Protein Family Members reveals 
Presumptive Bacterial Origin of TcOYe
To examine how TcOYE is related to other proteins sharing 
sequence similarity, we performed a phylogenetic analysis 
(Figure 1) using proteins annotated as Old Yellow Enzymes in 
the KEGG Orthology database and manually recovered from 
published studies (multiple sequence alignment is shown in 
Figure S2 in Supplementary Material). NCBI-CD search (25) and 
Pfam (26) were used to confirm the presence of the characteristic 
protein domains (“TIM_phosphate_binding superfamily” and 
“Oxidored_FMN”) in the selected group of protein sequences. 
This analysis evidenced that OYEs clustered in two major line-
ages, one comprising proteins exclusively from Bacteria and 
Archaea, and another which included fungal, plant, protozoan, 
and also bacterial proteins. TcOYE clustered in the group mainly 
formed by sequences from the phylum Proteobacteria, suggesting 
that TcOYE possibly originated through horizontal gene transfer 
from this group of bacteria to T. cruzi.
TcOYE is located in the cytosol  
and is expressed in epimastigotes  
and amastigotes
TcOYE subcellular localization was analyzed by indirect immu-
nofluorescence (IIF) and western blot with differential membrane 
permeabilization assays. TcOYE localization in epimastigotes is 
diffuse and cytoplasmic (Figure  2) in contrast to the granular 
appearance observed in early intracellular amastigotes (Figure 
S4 in Supplementary Material). In IIF assays TcOYE presents 
co-localization exclusively with the cytosolic tryparedoxin per-
oxidase (TccTXNPx), but not with mitochondrial tryparedoxin 
peroxidase (TcmTXNPx) and cruzipain (TcCZP), mitochondrial, 
and reservosomal proteins, respectively (Figure 2). In addition, 
when epimastigotes were lysed with increasing concentrations 
of digitonin, TcOYE displayed a similar pattern to TccTXNPx 
(cytosolic), and different from mitochondria (TcmTXNPx), 
reservosome (TcCZP), glycosome (TcGlck, glucokinase), and 
endoplasmic reticulum (TcAPX, ascorbate peroxidase) markers, 
supporting a cytosolic distribution of TcOYE in epimastigotes 
(Figure S5 in Supplementary Material).
TcOYE expression during T. cruzi lifecycle was analyzed 
by western blot using total extracts from different parasite 
stages (Figure 3A). A unique protein band of the expected size 
(42  kDa) was recognized by the polyclonal rabbit antiserum, 
confirming TcOYE expression in epimastigotes and amastigotes, 
FigUre 1 | Evolutionary relationship of Old Yellow Enzyme proteins. The structure-based sequence alignment was performed using the accurate mode of T-Coffee 
software. The tree was built with the Maximum Likelihood method with WAG as best-fit model. Species name, protein ID, and KEGG/NCBI accession numbers of 
these sequences are shown in Table S1 in Supplementary Material.
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with 2.5-fold higher expression in epimastigotes. In contrast, the 
protein displayed undetectable levels in cell-derived trypomas-
tigotes. The expression profile was further studied in the whole 
infective cycle by IIF (Figure 3B). TcOYE expression was unde-
tectable in early infection stages, and as parasites differentiated 
into amastigotes, TcOYE expression increased gradually being 
maximal at 48 h post infection. Upon completion of the intracel-
lular cycle, when parasites differentiate into trypomastigotes, 
the protein decreases again to undetectable levels. Furthermore, 
TcOYE and TccTXNPx expression was compared in intracellular 
amastigotes and trypomastigotes mixed groups [being TccTXNPx 
a constitutive enzyme (27)]. Figure  3C shows that TcOYE is 
expressed in amastigotes but becomes undetectable when these 
are differentiating into trypomastigotes, whereas TccTXNPx can 
be detected in both amastigotes and trypomastigotes.
TcOYe Overexpressing Parasites  
increase PgF2α Production
To study the different aspects of TcOYE involvement in T. cruzi 
infection process, overexpressing parasites were developed 
transfecting parasites with pTREX-n vector containing TcOYE 
complete ORF. TcOYE expression level was more than three 
times higher in overexpressing parasites than in control parasites 
(Figure 4A) and the overexpression was maintained along the 
entire cycle, including trypomastigotes (Figure  4B). Similar 
cell growth kinetics were observed for overexpressing parasites 
compared to controls, indicating that TcOYE augmentation has 
no detrimental effect in epimastigotes proliferation (Figure 4C). 
To uncover if TcOYE possesses PGF2α synthase activity in vivo, 
epimastigotes and trypomastigotes overexpressing TcOYE were 
incubated with AA as a substrate for prostaglandin synthesis and 
PGF2α was measured in pellets and supernatants (Figures 4D,E). 
In both stages, TcOYE overexpression correlates with an increase 
in PGF2α levels and this increase is statistically significant in 
overexpressing trypomastigotes compared to controls; possibly 
because basal activity in this life form is very low compared to 
epimastigotes. These results suggest that when the precursor is 
available TcOYE acts as a PGF2α synthase in the parasite.
TcOYe Overexpression confers 
susceptibility to Bzn and nfx and 
resistance to hydrogen Peroxide
Since recombinant TcOYE has been previously related to trypano-
cidal drugs metabolism (17, 24), we studied the effect of Bzn and 
Nfx treatment in TcOYE overexpressing parasites. Transfected 
FigUre 2 |  TcOYE presents citosolic localization in epimastigotes. Immunolocalization of TcOYE, TccTXNPx, TcCZP, and TcmTXNPx in epimastigotes using rabbit 
α-TcOYE (1/3,000) and mouse α-TccTXNPx (1/100), α-TcCZP (1/50), and α-TcmTXNPx (1/100) polyclonal antibodies. Bar: 5 µm. DAPI was used as nucleus and 
kinetoplast marker.
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epimastigotes overexpressing TcOYE were more susceptible to 
Bzn and viability decreased in all the assayed drug concentra-
tions (Figure 5A). Besides, overexpressing parasites had higher 
sensitivity to Nfx than control parasites (Figure 5B).
Reduction of hydrogen peroxide (H2O2) by recombinant 
TcOYE in anaerobic conditions has been previously described 
(17). To determine if TcOYE participates in the redox metabolism, 
we exposed TcOYE overexpressing epimastigotes to this oxidant. 
We observed a significant twofold increase in the viability of 
overexpressing parasites compared to controls (Figure 5C), evi-
dencing that TcOYE overexpression confers peroxide resistance. 
In addition, morphological changes evidenced in H2O2-treated 
control parasites were not observed in TcOYE overexpressing 
parasites (Figure S6 in Supplementary Material). Furthermore, 
we observed H2O2 exposure increased TcOYE expression in wild-
type epimastigotes (Figure S7 in Supplementary Material).
TcOYe Overexpression Modifies 
Trypanosoma cruzi infection cycle In Vitro
To get insight into the role of TcOYE during mammalian cell 
infection, infectivity was evaluated in vitro in overexpressing and 
control parasites. There were no differences neither in the invasion 
ability nor in the replicative capacity of TcOYE overexpressing 
parasites in comparison to controls (Figures 6A,B). Nevertheless, 
the amount of trypomastigotes released in the supernatant of 
infected cells was lower in transfectant parasites, suggesting that 
overexpression of the enzyme reduces the ability to complete the 
infective cycle. This effect was observed both in non-phagocytic 
and phagocytic cell lines (Figures 6C,D).
Mice infected with TcOYe Overexpressing 
Parasites showed an early Parasitemia 
Peak and higher heart Muscle Parasitic 
load
Considering eicosanoids were described as immunomodula-
tory factors during parasitic infections (12), we studied the 
TcOYE overexpression effect on parasitemia modulation and 
cardiac affection during mice infection. Control parasites 
produced a peak of parasitemia between 12 and 15 days post 
infection (dpi), while the peak of parasitemia in animals 
infected with TcOYE overexpressing parasites occurred on day 
6 (Figure 7A). Moreover, mice infected with TcOYE transfect-
ants presented an increased parasite load in the cardiac tissue 
(Figure 7B).
FigUre 3 |  TcOYE is expressed in replicative stages of Trypanosoma cruzi lifecycle. (a) TcOYE expression during the parasite lifecycle was evaluated by western 
blot with total protein extracts from different parasite stages and Vero cells (since trypomastigotes and amastigotes are derived from infected Vero cells, they were 
used as a cross-reactivity control), using rabbit TcOYE antiserum. Relative expression was estimated by densitometry normalized by tubulin expression. V, Vero cells, 
T, trypomastigotes, A, intracellular amastigotes, E, epimastigotes. (B) Kinetics of TcOYE expression during mammalian cells infective cycle. Parasites were followed 
by inmunocitolocalization with rabbit α-TcOYE polyclonal antibodies. Bar 10 µm (except 1–9 h 5 µm). (c) Confocal microphotographs showing TcOYE and 
TccTXNPx immunolocalization in different stages of Vero cells infection. Bar 10 µm.
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FigUre 5 | TcOYE overexpressing parasites present differential viability to benznidazole (Bzn), nifurtimox (Nfx), or hydrogen peroxide (H2O2). (a) Viability 
percentages of transfected parasites challenged with different concentrations of Bzn. (B) Viability percentages of transfected parasites challenged with different 
concentrations of Nfx. (c) Viability percentages of transfected parasites challenged with different concentrations of hydrogen peroxide. The percentages of cell 
viability are normalized against parasites without treatment. Values are the means of three independent assays performed in quadruplicate. Asterisks represent 
statistical significance (two tailed Student’s t-test).
FigUre 4 |  TcOYE overexpressing parasites presents higher levels of PGF2α than control parasites. (a) Western blot analysis of total protein extracts from 
epimastigotes transfected with pTREX-n (empty vector) and pTREX-n TcOYE (includes complete TcOYE coding sequence) using rabbit α-TcOYE polyclonal 
antibodies. The relative expression was estimated by image densitometry analysis normalized by tubulin expression. TcOYE overexpression in epimastigotes was 
3.4 times more than controls. (B) Trypomastigotes and extracellular amastigotes overexpression analyzed by IIF using rabbit α-TcOYE polyclonal antibodies. (c) 
Growth curves of TcOYE overexpressing parasites (pTREX-n TcOYE) vs. empty vector containing parasites (pTREX-n). (D,e) Determination of PGF2α in epimastigotes 
and trypomastigotes. These results correspond to concentration values of PGF2α from two replicates. Asterisks represent statistical significance (two tailed Student’s 
t-test).
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DiscUssiOn
TcOYE has been extensively studied, being most efforts focused 
on characterizing its reductive activity on nitroheterocyclic 
compounds (17, 22, 24, 28–32). Several roles have been attrib-
uted to TcOYE, including drug metabolism, reduction of dif-
ferent compounds, and prostaglandin synthesis, although these 
reports were based on the non-infective insect-derived forms 
FigUre 6 | TcOYE overexpression modulates parasite infective cycle. (a) Trypanosoma cruzi invasion capacity was not affected by TcOYE overexpression. HeLa 
cells were incubated for 4 h with trypomastigotes and then the number of infected cells vs. total cells was evaluated. At least 200 cells per replicate were evaluated. 
No statistically significant differences were observed between the means of three independent assays performed in triplicates. (B) Intracellular amastigotes 
replication was not affected by TcOYE overexpression. HeLa cells were incubated for 4 h with trypomastigotes and the number of internal parasites was counted 
48 h post infection in at least 100 cells. No statistically significant differences were observed between the means of three independent assays performed in 
triplicates. (c,D) TcOYE overexpression reduces the capacity of parasites to complete the infective cycle in different cell types. Number of trypomastigotes per 
milllilter of supernatant of HeLa cell or J774 macrophages infected with pTREX-n control parasites or pTREX-n TcOYE transfected parasites. Asterisks represent 
statistical significance (two tailed Student’s t-test).
FigUre 7 | TcOYE overexpression increased cardiac tissue parasite load in infected mice. (a) Parasitemia progression in BALB/c mice infected with TcOYE 
overexpressing and control parasites. Parasitemia was measured every 3 days by microscopic examination of thin tail-blood smears. (B) Parasite load in cardiac 
tissue of mice infected with transfected Trypanosoma cruzi euthanized at the 30th dpi. N = 2–5. Asterisks represent statistical significance (two tailed Student’s 
t-test).
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of the parasite or using the recombinant protein. However, lit-
tle is known about its biological role and possible implication 
in host–pathogen interaction through in  vivo models. In this 
work, we present a functional characterization of this enzyme 
which, together with related enzymes TcAKR and TcNTRI, are 
important proteins associated with the metabolism of the current 
anti-chagasic drugs (16, 17, 33). Our work is focused on poorly 
understood aspects of TcOYE including its evolutionary origin, 
its role in mammalian infection, its expression and subcellular 
localization along the lifecycle, as well as its role as PGF2α syn-
thase in vivo.
Considering that TcOYE is only found in T. cruzi, and not 
in other trypanosomatids, we were interested in studying its 
evolutionary relatedness with representative eukaryotic and 
prokaryotic OYE proteins, to make inferences about its evolu-
tionary origin and possible roles. To date, homologs have been 
identified only in bacteria (34), plants (35), fungi (19), and some 
protozoa (17, 36), having different roles depending on the organ-
ism. OYE proteins have been associated with oxidative stress 
response, detoxification of oxygenated lipids and with different 
specific metabolic pathways (21). Our phylogenetic characteriza-
tion revealed that TcOYE is phylogenetically closer to bacterial 
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proteins than from other eukaryotes and, in particular, it formed 
a monophyletic group with Gammaproteobacteria indicating 
a possible gene transfer from this group of bacteria to T. cruzi. 
Among these organisms, Dickeya dadantii belongs to the family 
Enterobacteriaceae; and there are also several species of Vibrio 
which cause gastrointestinal tract diseases. Noteworthy, T. cruzi is 
stercoraria and during the epimastigote stage resides in a micro-
environment with a high diversity of bacteria, a possible scenario 
for a horizontal gene transfer (37).
We studied TcOYE expression along the T. cruzi life cycle 
using two different approaches demonstrating its highly regulated 
expression. TcOYE was detected in replicative parasite forms 
(epimastigotes and amastigotes) but not in non-replicative cell-
derived trypomastigotes. In particular, we found that TcOYE is 
undetectable in trypomastigotes before mammalian cell infection 
and also when parasites start to differentiate into intracellular try-
pomastigotes, suggesting the protein is not relevant at the begin-
ning and end of the intracellular infection cycle. Accordingly, 
TcOYE (referred as dehydrogenase) has been identified in 
epimastigotes using alkaline bi-dimensional gels, whereas it was 
not detected when trypomastigote extracts were used (38). Also, 
the same differential protein pattern was observed by means of 
MudPIT proteomics (39). The lower or null TcOYE expression in 
cell-derived trypomastigotes could be a consequence of mRNA 
downregulation at this stage, a differential protein translation or 
degradation. In this sense, using available data from two different 
transcriptomic analysis (2, 40), we compared the mRNA levels of 
TcOYE (not shown) in different stages. Even though mRNA levels 
are higher in epimastigotes than in the other stages (in agreement 
with our observations at protein level), no significant differences 
were observed between amastigotes and trypomastigotes. These 
results suggest TcOYE is being regulated by posttranscriptional 
mechanisms, which are widely used by these parasites. Regarding 
the role of TcOYE in mammalian cell infection, later stages of the 
in vitro infection process were affected when parasites expressed 
TcOYE constitutively (pTREX-n TcOYE transfected line). 
Parasites were able to invade cells and replicate intracellularly but 
presented an impaired capacity to complete the infective cycle, 
since the amount of released trypomastigotes was reduced. This 
result, together with the observed reduction in TcOYE levels dur-
ing differentiation from amastigotes to trypomastigotes discussed 
above, suggested that a reduction in TcOYE expression levels 
may be needed to fulfill the infective cycle. In a similar experi-
ment using different T. cruzi strains, it was reported that TcOYE 
overexpression causes a reduction in the number of intracellular 
amastigotes (32). Although in both cases the infection cycle is dis-
turbed negatively, the differences could be attributed to different 
strains background. Recombinant TcOYE is able to reduce PGH2 
(11, 17) but, taking into account the wide range of substrates 
that can be reduced by this protein family on in vitro assays, we 
aimed to uncover if TcOYE presents this activity in the parasite 
in presence of AA. In fact, PGF2α levels in TcOYE overexpressing 
trypomastigotes were higher than in control parasites, demon-
strating this enzyme is responsible for this activity in the parasite. 
Since TcOYE expression is undetectable in trypomastigotes, we 
could determine significant differences in PGF2α synthesis among 
overexpressing and control parasites at this stage. This result 
also indicates that parasites can uptake the precursors from the 
extracellular media to produce its prostaglandins. Finally, a high 
level of PGF2α was found in culture supernatants, suggesting that 
this molecule is released from the parasite once it is synthesized, 
possibly to exert paracrine or endocrine effects.
Extensive studies on OYEs substrate specificity have suggested 
a role in detoxification and oxidative metabolism. The expression 
of OYE2 from Saccharomyces cerevisiae and YqjM from Bacillus 
subtilis is induced in response to oxidative stress and the exposure 
to toxic xenobiotics, evidencing an antioxidant role (34, 41). In 
T. cruzi, a peroxidase activity has been demonstrated in  vitro 
for the recombinant TcOYE (17). Accordingly, we observed an 
enhanced resistance to H2O2 in TcOYE overexpressing parasites 
and an increased expression of this protein in wild-type parasites. 
In this context, TcOYE could possibly acts as an antioxidant 
metabolizing lipid peroxidation products produced by H2O2 
exposition, as previously described in S. cerevisiae (41). Although 
a pro-oxidant role has been proposed for this enzyme (32), our 
results showing an antioxidant role of TcOYE are in agreement 
with the peroxidase activity described by Kubata et al. (17), and 
extensive evidence supports a protective role against oxidative 
stress conserved across the OYE family (34, 42, 43).
It has been proposed that recombinant TcOYE uses NADPH 
to reduce Nfx under anaerobic conditions activating the prodrug 
(17). TcOYE gene deletions were also associated with Bzn resist-
ance induced in  vitro (24) and recently TcOYE overexpressing 
parasites were shown to have higher sensitivity to Bzn (32). 
Accordingly, we found that TcOYE overexpression produced 
an increased susceptibility to both Bzn and Nfx. These results 
indicate that TcOYE participates in the activation of Bzn and Nfx 
in vivo. In this sense, Wilkinson et al. demonstrated an increased 
resistance to Nfx and Bzn when both TcNTRI and TbNTRI, 
other type I nitroreductases, decreased their expression; whereas 
overexpression produced hypersensitivity (44). We demonstrated 
with functional studies that TcOYE overexpression produced the 
same effect as TcNTRI when the parasites are exposed to these 
prodrugs. Beyond its biological significance, TcOYE is relevant 
given its nitroreductase activity and the ability to activate prod-
rugs that are used against Chagas disease.
TcOYE overexpressing parasites used for infections in mice 
produced an earlier parasitemia peak and increased cardiac 
parasitic load. This result is relevant since myocardial damage due 
to persistence of the parasite is considered the most important 
mechanism in the development of chagasic cardiomyopathy 
(45). In addition, cardiomyopathy is considered one of the most 
important manifestations of T. cruzi infection (46). The reduced 
TcOYE overexpressing parasites capacity to complete the lifecycle 
could explain the higher cardiac tissue parasitic load in infected 
mice. Nevertheless, more experiments are needed to understand 
the systemic mechanisms that are acting.
Several features uncover the importance of PGF2α activity 
for trypanosomatids. In particular, in T. cruzi, PGF2α is one of 
the most abundant prostanoid parasite-derived together with 
TXA2 (11). The reason why Trypanosoma cruzi has acquired an 
Old Yellow Enzyme with multiple functions and relevance in the 
host–parasite interactions as shown in this work, deserves further 
study.
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MaTerials anD MeThODs
Dna amplification and cloning
TcOYE coding sequence was PCR-amplified from genomic DNA 
of T. cruzi Dm28c epimastigotes with Pfu DNA polymerase 
(Fermentas) usings EcoRI_Fw_OYE: (5′-AAGAATTCATGGCG 
ACGTTCCCTGAACTTCTG-3′), HindIII_Rv_cSTOP_OYE: 
( 5 ′ - A A A A A G C T T T T A G T T G T T G T A C G T C G G 
GTAATCGT-3′), and KpnI_FwOYE (5′-AAGGTACCATGGCG 
ACGTTCCCTGAACTTC-3′) primers. PCR products were 
cloned in pGEM®-T Easy plasmid (Promega, USA) using T4 DNA 
Ligase (Sigma) and sequenced. EcoRI_Fw_OYE and HindIII_
Rv_cSTOP_OYE primers were used to subclone into pTREX-n 
vector (47), and KpnI_FwOYE and HindIII_Rv_cSTOP_OYE for 
pQE30 vector (Qiagen).
expression and Purification of 
recombinant Proteins
Recombinant 6His-tag fusion protein was expressed in M15 
Escherichia coli strain. Cells were grown on LB medium sup-
plemented with ampicillin (50 µg/ml) and kanamycin (25 µg/ml) 
at 37°C until OD600 nm ~0.6. Induction of protein expression 
was performed with 1 mM IPTG at 37°C for 4 h. Recombinant 
TcOYE purification under native conditions was performed using 
FPLC A¨KTA™ purifier (GE Healthcare Life Sciences) in two steps: 
immobilized-metal affinity chromatography using HisTrap High 
Performance™ column (GE Healthcare) and anion exchange 
chromatography with a RESOURCE Q column (GE Healthcare). 
The recombinant proteins purity was analyzed by SDS-PAGE 
12% stained with colloidal coomassie (Brilliant Blue G-250, 
Sigma), and protein concentration was determined by Bradford 
method (48).
Polyclonal antiserum against TcOYE was obtained from New 
Zealand White rabbits after intraperitoneal injection of 100 µg of 
recombinant TcOYE in Freund’s Complete Adjuvant (Sigma), fol-
lowed by two immunizations with 50 µg of recombinant protein 
in Freund’s Incomplete Adjuvant (Sigma). Serum was obtained 
15 days after the last boost.
Western Blotting
Proteins resolved by electrophoresis in 12% acrylamide gels 
under reducing conditions were transferred to nitrocellulose 
membranes Amersham™ HybondTM-ECL (GE Healthcare). 
Membranes were blocked for 2 h with blocking solution [3% (w/v) 
BSA, 0.1% (v/v) Tween 20 in PBS]; followed by 10 min in wash 
solution [0.1% (v/v) Tween 20 in PBS]. Membranes were incu-
bated with antibodies diluted in 1% (w/v) BSA, 0.1% (v/v) Tween 
20 in PBS for 3 h, washed three times with wash solution 10 min, 
and incubated for 1 h with HRP-conjugated goat anti-rabbit or 
anti-mouse secondary antibody (Sigma or DAKO, respectively). 
Finally, membranes were washed four times for 10  min with 
wash solution. The whole procedure was performed at room 
temperature. The signal was developed with Super Signal® West 
Pico Chemiluminescent Substrate (Thermo SCIENTIFIC, USA) 
according to the manufacturer’s specifications. The normaliza-
tion was performed with α-tubulin commercial antibody (Sigma, 
T5168) and bands were scanned and quantified using ImageJ 
1.49m software. Rabbit TcOYE antiserum was diluted 1/30,000.
Parasites and cells
Vero (49), macrophage-like cell line J774 (50), and HeLa (51) 
cells were cultivated in Dulbecco’s Modified Eagle’s Medium 
[DMEM(1×) +  GlutaMAX™-l, Gibco® by Life Technologies™] 
supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco), 
penicillin 100  U/ml and 100  µg/ml streptomycin (Thermo 
SCIENTIFIC) at 37°C in a humidified 5% CO2 atmosphere.
Trypanosoma cruzi Dm28c (52) were cultured axenically in 
liver infusion tryptose medium supplemented with 10% (v/v) 
inactivated fetal bovine serum (GIBCO) at 28°C. Trypomastigotes 
were collected from the supernatant of infected monolayers 
of Vero cell lines and were maintained cyclically. Intracellular 
amastigotes were obtained from infected Vero monolayers using 
Iodixanol gradient. Briefly, infected cells were washed with cold 
PBS twice, resuspended in cold PBS supplemented with complete 
protease inhibitor cocktail, and scrapped. Cells were then lysed in 
a Dounce homogenizer. The homogenate (2 ml) was added slowly 
into 2 ml of iodixanol 16% in a 15-ml falcon and then centrifuged 
at 800 g for 15 min. The amastigotes enriched pellet was isolated 
and resuspended in cold PBS. The purity of the preparation was 
evaluated under a microscope.
Trypanosoma cruzi epimastigotes were transfected with 
pTREX-n (empty vector) or pTREX-n TcOYE construction. 
Epimastigotes (8 × 107) were resuspended in HBS Buffer (21 mM 
HEPES, 137 mM NaCl, 5 mM KCl, 6 mM glucose, pH 7.4) and 
electroporated with 100 µg of plasmid DNA using two pulses at 
450 V, 1,300 μF, and 13 Ω in 4-mm cuvettes. Transfected para-
sites were then selected with increasing concentrations of G418 
(Sigma) from 50 to 500 µg/ml. Overexpression was confirmed by 
western blot analysis and IIF using the Icy platform (http://icy.
bioimageanalysis.org).
Dna and Protein extraction
DNAzol® Reagent (Invitrogen) was used according to the manufac-
turer’s specifications for isolation of genomic DNA of T. cruzi Dm28c 
epimastigotes. The DNA was resuspended in sterile distilled water 
and stored at −20°C until use. Quantification was performed using 
a spectrophotometer NanoDrop™ 1000 (Thermo SCIENTIFIC).
To obtain total protein extracts from epimastigotes, amas-
tigotes, and trypomastigotes from Dm28c strain, parasites were 
washed three times in cold PBS and one time with 10 mM Tris pH 
7 to remove remnant salts. Then, 50 µl of lysis buffer [40 mM Tris 
base, 7 M urea, 2 M tiourea, 4% (w/v) CHAPS, 1 mM PMSF, 1% 
(w/v) DTT, 1× complete protease inhibitor cocktail (Sigma, REF 
11873580001), nuclease mix] was added for each 1 × 106 para-
sites. Lysates were vortexed for 1–3 min and then the solution was 
incubated 30 min at room temperature with gentle agitation to 
allow complete lysis. The lysates were centrifuged at 12,500 rpm 
for 30  min and the supernatant was stored at −80°C. Proteins 
were quantified with Bradford reagent (Sigma).
immunolocalization studies
For IIF localization, parasites were fixed for 16  h at 4°C with 
4% (w/v) paraformaldehyde and then incubated with 50  mM 
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ammonium chloride (Sigma) for 10  min at room temperature. 
Parasite (1 ×  106) were settled in polylysine pre-treated slides 
and permeabilized 5 min with 0.5% (v/v) Triton-X100 (Sigma). 
Blocking was performed with 2% (w/v) BSA, 0.1% (v/v) Tween 
20 in PBS for 1 h, and washing with 0.1% (v/v) Tween 20 in PBS. 
Cells were incubated with polyclonal antibodies anti-TcOYE 
(1/3,000 dilution), anti-TccTXNPx (1/100), anti-TcCZP (1/50), 
anti-TcmTXNPx (1/100) primary antibodies for 1 h. After three 
washes, Alexa Fluor® 488 goat anti-rabbit IgG (Invitrogen, A11034) 
and Alexa Fluor® 546 goat anti-rabbit IgG (Invitrogen, A11010) 
or Cy3® goat anti-mouse IgG (Invitrogen, M30010) secondary 
antibodies were added for 1 h at a 1/1,000 (v/v) dilution. After 
four washes, slides were mounted with Fluoroshield™ with DAPI 
(Sigma) and visualized under Leica TCSSP5 confocal microscope. 
The whole procedure was performed at room temperature.
For differential membrane permeabilization assays, 5 ×  108 
epimastigotes were treated with increasing concentrations of 
digitonin (AppliChem) from 0 to 4  mg/ml (53). Parasites were 
washed once with PBS and twice with extraction buffer (20 mM 
Tris–HCl, 100 mM NaCl, 1 mM EDTA, 250 mM sacarose, pH 
7.5). Parasites were resuspended in 850  µl of extraction buffer 
and 80 µl of this resuspension was incubated 5 min at 30°C with 
the corresponding digitonin dilution. Protein fractions were 
centrifuged for 10 min 15,500 g at 4°C, and supernatants were 
blended with loading buffer, boiled 5  min and conserved at 
−20°C. Protein extracts were employed in western blot analysis 
using different polyclonal sera as specific localization markers: 
TccTXNPx (cytosolic tryparedoxin peroxidase; cytoplasmatic; 
diluted 1/20,000), TcGlck (Glucokinase; glycosomal; diluted 
1/2,000), TcmTXNPx (mitochondrial tryparedoxin peroxidase; 
mitochondrial matrix; diluted 1/2,000), TcCZP (cruzipain; res-
ervosome; diluted 1/1,000), and TcAPX (ascorbate peroxidase; 
endoplasmic reticulum; diluted 1/4,000).
T. cruzi Mammalian cell infection and 
invasion assays
HeLa (30,000 cells/well) and macrophage-like cell line J774 
(50,000  cells/well) cells were cultured onto 18-mm round glass 
coverslips in 12 wells plates (Corning Inc., Corning, NY, USA). 
Cells were infected with cell-derived trypomastigotes (pTREX-n 
or pTREX-n TcOYE) at a ratio of five parasites per cell in DMEM 
without FBS. After 4 h of interaction, non-internalized parasites 
were removed by PBS washes and fresh DMEM supplemented 
with 2% (v/v) FBS was added. At different times coverslips were 
washed with PBS, fixed with 95% (v/v) ethanol and stained with 
Fluoroshield™ with DAPI (Sigma). Infectivity was assessed con-
sidering invasion, intracellular replicative capacity, and trypomas-
tigote generation. Invasion capacity was evaluated by counting the 
number of infected cells after 4 h of interaction. Replication was 
analyzed as the number of amastigotes per infected cell at 48 h post 
infection. Internalized parasites were determined by Olympus 
IX81 microscope. Trypomastigotes completing the infective cycle, 
present in the supernatant every 24 h, were also counted.
susceptibility experiments
TcOYE overexpressing epimastigotes (5 × 106) were washed twice 
with 1% (w/v) Glucose in PBS and then incubated 24 h with Bzn or 
Nfx (20, 50, and 100 µM) or 48 h with H2O2 (200 and 300 µM) in 
the same media. Parasites transfected with the empty vector were 
used as controls. The viability was evaluated with the resazurin 
reagent (R7017, Sigma) measuring absorbance at 490 and 595 nm. 
Results are referred to the condition of parasites without treatment.
PgF2α synthase activity
TcOYE overexpressing epimastigotes and trypomastigotes were 
washed with PBS and incubated with 50 µM of AA (ab120916, 
Abcam) in PBS for 2 h. Parasites were removed by pelleting at 
1,100 g for 10 min. Parasite-free supernatant was stored at 4°C 
until PGF2α measurement with PGF2 alpha High Sensitivity 
ELISA Kit (ab133056, Abcam). The parasites were resuspended 
in PBS and an extract was performed by thermal shock (15 min at 
−80°C and 15 min at 37°C for three times consecutively). Finally, 
the resulting homogenized was centrifuged at 20,000 g for 30 min 
at 4°C and the supernatant was used for PGF2α determination. 
The measurements were performed in duplicate.
animal infection
Intraperitoneal infection of 8-week-old male BALB/c mice was 
performed with TcOYE overexpressing and control parasites. 
Mice were obtained from the Animal Facilities at the Faculty 
of Medicine, University of Chile and were maintained in a con-
trolled environment under a 12-h day/night cycle at a constant 
temperature, with food and water available ad libitum as it was 
previously described by González-Herrera et al. (54).
Mice were intraperitoneally inoculated with 2 ×  104 blood 
trypomastigotes distributed in three groups: two mice were 
infected with wild-type parasites, five mice were infected with 
pTREX-n parasites and five mice were infected with pTREX-n 
TcOYE parasites. Direct microscopic visualization of circulating 
trypomastigotes in thin tail-blood smears was used to evaluate 
T. cruzi infection every 3 days for a month. At 30th dpi, animals 
were euthanized and the hearts were obtained to evaluate parasite 
load in cardiac tissue. The hearts were conserved in 95% (v/v) 
ethanol for DNA extraction.
real-time Pcr
Wizard Genomic DNA Purification Kit (Promega, USA) was used 
according to the manufacturer’s specifications for isolation of 
genomic DNA from heart samples from T. cruzi-infected BALB/c 
homogenized. qPCR reactions were performed in duplicate with 
SYBR® Green PCR Master Mix (Thermo Fisher Scientific, USA) 
using TCZ1 (5′-CGAGCTCTTGCCCACACGGGTGCT-3′) and 
TCZ2 (5′-CCTCCAAGCAGCGGATAGTTCAGG-3′) primers, 
which amplify a 188-bp nDNA microsatellite region of T. cruzi 
genome (55). TNFα-5241 (5′-TCCCTCTCATCAGTTCTATGG 
CCCA-3′) and TNFα-5411 (5′-CAGCAAGCATCTATGCACTTA 
GACCCC-3′) primers were used as a loading control, since they 
are species-specific for Mus musculus a 170-bp sequence from 
TNFα gene. Real-time qPCR amplifications were performed 
using a 7300 Real-Time PCR system (Applied Biosystems, USA).
statistical analysis
GraphPad Prism ® Version 5.0 (GraphPad Software, Inc.) was 
used to determine statistically significant differences. Three 
11
Díaz-Viraqué et al. Old Yellow Enzyme from T. cruzi
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 456
technical replicates were assayed for each experiment, in at 
least two biological replicates. Data are present as mean ±  SE. 
Statistical significance was assumed with probability values less 
than or equal to 0.05 using the following convention: *P ≤ 0.05; 
**P ≤ 0.01; ***P ≤ 0.001.
Phylogenetic analysis of characterized 
Members of the Old Yellow enzyme 
Protein Family
A representative set of well-known OYE (n = 78) sequences were 
obtained from KEGG Orthology database (56) and NCBI (Table 
S1 in Supplementary Material). Sequences with the characteris-
tic domains of the family were used to perform phylogenetic and 
other comparative analyses. The protein sequences were multiply 
aligned using the accurate mode of T-coffee (57). This method 
takes into account the 3D structures available for improving the 
alignment quality. ProtTest v3.2.2 (58) was applied to find an 
optimal substitution model for each alignment. WAG (Whelan 
and Goldman) was the best-fit model. Phylogenetic analyses 
were performed with the maximum-likelihood method using 
the program PhyML (59). For the visualization FigTree v1.4.2 
was used.
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TaBle s1 | Old Yellow Enzyme proteins.
FigUre s1 | Phylogenetic analysis of proteins annotated as Old Yellow Enzyme.
FigUre s2 | OYE sequences analysis. (a) Multiple sequence alignment of full 
length OYE proteins carrying a single domain from bacteria, archaea, plants, 
fungi, and protozoa using the accurate mode of T-coffee. The positions of the 
core active site residues are highlighted with the rectangular boxes. (B,c) Pfam 
and NCBI-CD search domain are highlighted in the full length OYE protein from 
Trypanosoma cruzi (TcOYE).
FigUre s3 | Expression and purification of recombinant TcOYE. SDS-PAGE 
12% stained with colloidal coomassie. Recombinant 6His-tag fusion protein was 
expressed in M15 Escherichia coli strain. The protein purification was performed 
under native conditions in two steps: immobilized-metal affinity chromatography 
(IMAC) and anion exchange chromatography.
FigUre s4 | Immunofluorescence confocal images of intracellular amastigotes. 
Inmunofluorescence images of intracellular amastigotes using rabbit α-TcOYE 
antiserum (1/3,000). Bar: 5 µm. DAPI was used as nucleus and kinetoplast marker.
FigUre s5 | Digitonin titration of TcOYE in Trypanosoma cruzi epimastigotes. T. 
cruzi epimastigotes were permeabilized with increasing digitonin concentrations 
and the samples were evaluated by western blot using α-TcOYE (1/30,000), 
α-TccTXNPx (1/20,000), α-TcGlck (1/2,000), α-TcmTXNPx (1/2,000), α-TcCZP 
(1/1,000), and α-TcAPX (1/4,000) polyclonal antibodies.
FigUre s6 | Morphological changes observed during hydrogen peroxide treatment.
FigUre s7 | TcOYE expression increase in parasites exposed to hydrogen 
peroxide. Western blot analysis of total protein extracts from wild-type 
trypomastigotes exposed to H2O2 using α-TcOYE (1/20,000). T0, vehicle control 
(without H2O2); T1, 10 min; T2, 20 min; T3, 40 min.
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